NCT03417739 2026-02-25A Phase II Study of BVD-523 in Metastatic Uveal MelanomaDana-Farber Cancer InstitutePhase 2 Terminated13 enrolled 9 charts
NCT03865212 2026-01-28Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV MelanomaMayo ClinicPhase 1 Terminated12 enrolled